Candida spp. co-infection in COVID-19 patients with severe pneumonia: Prevalence study and associated risk factors - 23/10/21
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
Background |
Invasive fungal infections (IFI) are increasing in prevalence in recent years. In the last few months, the rise of COVID-19 patients has generated a new escalation in patients presenting opportunistic mycoses, mainly by Aspergillus. Candida infections are not being reported yet.
Objectives |
We aimed to determine the prevalence of systemic candidiasis in patients admitted to ICUs due to severe pneumonia secondary to SARS-CoV-2 infection and the existence of possible associated risk factors that led these patients to develop candidiasis.
Patients/methods |
We designed a study including patients with a confirmed diagnosis of COVID-19.
Results |
The prevalence of systemic candidiasis was 14.4%, and the main isolated species were C. albicans and C. parapsilosis. All patients that were tested positive for Candida spp. stayed longer in the ICU in comparison to patients who tested negative. Patients with candidiasis had higher MuLBSTA score and mortality rates and a worse radiological involvement. In our study, Candida spp. isolates were found in patients that were submitted to: tocilizumab, tocilizumab plus systemic steroids, interferon type 1β and Lopinavir-Ritonavir.
Conclusions |
Results suggested a high prevalence of systemic candidiasis in severe COVID-19-associated pneumonia patients. Patients with Candidiasis had the worst clinical outcomes. Treatment with tocilizumab could potentialize the risk to develop systemic candidiasis.
Le texte complet de cet article est disponible en PDF.Keywords : Candida, Systemic candidiasis, COVID-19, Viral pneumonia
Plan
Vol 188
Article 106619- novembre 2021 Retour au numéro
Article précédent
- Complications after discharge with COVID-19 infection and risk factors associated with development of post-COVID pulmonary fibrosis
- Dr Raminder Aul, Dr Jessica Gates, Dr Adrian Draper, Dr Anne Dunleavy, Dr Sachelle Ruickbie, Dr Helen Meredith, Dr Nicola Walters, Dr Cristiano van Zeller, Dr Victoria Taylor, Dr Michael Bridgett, Dr Roisin Dunwoody, Dr Sisa Grubnic, Dr Tersesa Jacob, Dr Yee Ean Ong
- Baseline lung allograft dysfunction in primary graft dysfunction survivors after lung transplantation
- David Li, Justin Weinkauf, Ali Kapasi, Alim Hirji, Rhea Varughese, Dale Lien, Jayan Nagendran, Kieran Halloran
Bienvenue sur EM-consulte, la référence des professionnels de santé.